GIBU
UTHR icon

Gulf International Bank (UK)’s United Therapeutics UTHR Stock Holding History

Gulf International Bank (UK)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.9M Buy
3,197
+819
+34% +$408K 0.04% 368
2025
Q4 		$1.16M Sell
2,378
-5
-0.2% -$2.33K 0.04% 391
2025
Q3 		$999K Hold
2,383
– – 0.03% 430
2025
Q2 		$684K Hold
2,383
– – 0.02% 511
2025
Q1 		$734K Sell
2,383
-1,274
-35% -$437K 0.03% 513
2024
Q4 		$1.29M Sell
3,657
-40
-1% -$14.7K 0.03% 430
2024
Q3 		$1.32M Sell
3,697
-229
-6% -$77.4K 0.03% 428
2024
Q2 		$1.25M Hold
3,926
– – 0.03% 433
2024
Q1 		$901K Buy
3,926
+23
+0.6% +$5.19K 0.02% 519
2023
Q4 		$858K Sell
3,903
-483
-11% -$111K 0.02% 521
2023
Q3 		$990K Sell
4,386
-388
-8% -$89.4K 0.03% 491
2023
Q2 		$1.05M Sell
4,774
-1,331
-22% -$295K 0.03% 506
2023
Q1 		$1.37M Buy
+6,105
New +$1.51M 0.03% 502
2019
Q2 		– Sell
-9,030
Closed -$1.06M – 739
2019
Q1 		$1.06M Hold
9,030
– – 0.02% 584
2018
Q4 		$983K Sell
9,030
-4,740
-34% -$550K 0.02% 577
2018
Q3 		$1.76M Hold
13,770
– – 0.02% 574
2018
Q2 		$1.56M Hold
13,770
– – 0.02% 641
2018
Q1 		$1.55M Sell
13,770
-330
-2% -$41.9K 0.02% 644
2017
Q4 		$2.09M Hold
14,100
– – 0.03% 611
2017
Q3 		$1.65M Hold
14,100
– – 0.02% 627
2017
Q2 		$1.83M Hold
14,100
– – 0.03% 616
2017
Q1 		$1.91M Buy
14,100
+180
+1% +$27.3K 0.03% 601
2016
Q4 		$2M Sell
13,920
-50
-0.4% -$6.38K 0.03% 598
2016
Q3 		$1.65M Hold
13,970
– – 0.03% 606
2016
Q2 		$1.48M Hold
13,970
– – 0.02% 616
2016
Q1 		$1.56M Hold
13,970
– – 0.03% 614
2015
Q4 		$2.19M Buy
13,970
+120
+0.9% +$17.5K 0.04% 510
2015
Q3 		$1.82M Sell
13,850
-1,200
-8% -$192K 0.03% 558
2015
Q2 		$2.62M Buy
+15,050
New +$2.71M 0.05% 458

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Gulf International Bank (UK)'s UTHR Position: Q1 2026 in Review

Gulf International Bank (UK) increased its United Therapeutics (UTHR) stake by 34% in Q1 2026, buying an estimated $408K and bringing the position to 3,197 shares worth $1.9M. The position accounts for 0.04% of the portfolio, ranked #368.

Gulf International Bank (UK) first reported a position in UTHR in Q2 2015 and has held it in 29 quarters since. The position peaked at $2.62M in Q2 2015. 852 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Gulf International Bank (UK) held 3,197 shares of United Therapeutics worth $1.9M as of Q1 2026.
  • Gulf International Bank (UK) bought 819 United Therapeutics shares in Q1 2026, an estimated $408K.
  • United Therapeutics made up 0.04% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #368 holding.
  • Gulf International Bank (UK) first reported a position in United Therapeutics in Q2 2015 and has held it in 29 quarters since.
  • Gulf International Bank (UK)'s United Therapeutics position peaked at $2.62M in Q2 2015.
  • 852 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.